Third dose vaccine, Ema: “It is for immunosuppressed people”

The third dose of the covid vaccine is for immunosuppressed people and some elderly people. “There is growing evidence that additional doses of the ‘anti-Covid’ vaccine need to be considered for people who may respond poorly to immunization, such as those with severely weakened immune systems or some elderly patients,” said Marco. Cavaleri, head of Vaccines and Therapeutic Products for Covid-19 of the European Medicines Agency Ema, during a press briefing. Ema, he recalled, “is evaluating an application for the use of an” additional “booster dose of the Comirnaty * vaccine (BioNTech / Pfizer), to be administered at least 6 months after the second dose to people of age or older. at age 16. Results are expected in the coming weeks, “Cavaleri pointed out, stressing that” other manufacturers may soon present data on a third booster dose. Moderna has started sending data from its clinical trial with booster doses. ” . Ema, Cavaleri specified, is working closely with the European Center for Disease Prevention and Control (Ecdc) to “collect and review data on booster doses”.